Kevin Luk

2.8k total citations
26 papers, 1.0k citations indexed

About

Kevin Luk is a scholar working on Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kevin Luk has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Epidemiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kevin Luk's work include CRISPR and Genetic Engineering (11 papers), Cardiac Valve Diseases and Treatments (3 papers) and Mosquito-borne diseases and control (3 papers). Kevin Luk is often cited by papers focused on CRISPR and Genetic Engineering (11 papers), Cardiac Valve Diseases and Treatments (3 papers) and Mosquito-borne diseases and control (3 papers). Kevin Luk collaborates with scholars based in United States, Canada and China. Kevin Luk's co-authors include Scot A. Wolfe, Daesik Kim, Jin‐Soo Kim, Jing Zeng, Daniel E. Bauer, Luca Pinello, Qiuming Yao, Pengpeng Liu, Yuxuan Wu and Chunyan Ren and has published in prestigious journals such as Nature, Nucleic Acids Research and Circulation.

In The Last Decade

Kevin Luk

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Luk United States 17 724 201 149 125 112 26 1.0k
Jean‐Marie Heslan France 20 305 0.4× 137 0.7× 45 0.3× 28 0.2× 32 0.3× 34 777
Ritsuko Seki Japan 15 266 0.4× 116 0.6× 53 0.4× 111 0.9× 33 0.3× 48 647
Claire Booth United Kingdom 22 412 0.6× 394 2.0× 187 1.3× 71 0.6× 24 0.2× 71 1.3k
Hanqin Lei United States 17 353 0.5× 104 0.5× 368 2.5× 32 0.3× 75 0.7× 22 980
Ralston M. Barnes United States 16 614 0.8× 101 0.5× 168 1.1× 19 0.2× 79 0.7× 25 802
Iván Martínez United States 16 935 1.3× 50 0.2× 187 1.3× 26 0.2× 23 0.2× 29 1.3k
Patrik Asp United States 14 801 1.1× 141 0.7× 82 0.6× 30 0.2× 16 0.1× 22 1.2k
Paritha Arumugam United States 20 502 0.7× 317 1.6× 50 0.3× 203 1.6× 17 0.2× 36 1.1k
Andrea Farina Italy 18 1.1k 1.6× 141 0.7× 72 0.5× 26 0.2× 164 1.5× 35 1.5k
Arend W. Overeem Netherlands 13 355 0.5× 125 0.6× 44 0.3× 33 0.3× 22 0.2× 17 801

Countries citing papers authored by Kevin Luk

Since Specialization
Citations

This map shows the geographic impact of Kevin Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Luk more than expected).

Fields of papers citing papers by Kevin Luk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Luk. The network helps show where Kevin Luk may publish in the future.

Co-authorship network of co-authors of Kevin Luk

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Luk. A scholar is included among the top collaborators of Kevin Luk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Luk. Kevin Luk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carrai, Maura, Yun Young Go, Kevin Luk, et al.. (2025). Characterization of biosecurity practices and viral infections on pig farms in Hong Kong. Preventive Veterinary Medicine. 242. 106569–106569. 1 indexed citations
2.
Amrani, Nadia, Kevin Luk, Meltem Isik, et al.. (2024). CRISPR-Cas9-mediated genome editing delivered by a single AAV9 vector inhibits HSV-1 reactivation in a latent rabbit keratitis model. Molecular Therapy — Methods & Clinical Development. 32(3). 101303–101303. 5 indexed citations
3.
Wang, Yetao, Lawrence M. Lifshitz, Noah J. Silverstein, et al.. (2023). Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV ‐1 pathogenesis. The EMBO Journal. 42(16). e114153–e114153. 8 indexed citations
4.
Shin, Masahiro, Kevin Luk, Sumio Isogai, et al.. (2023). Generation and application of endogenously floxed alleles for cell-specific knockout in zebrafish. Developmental Cell. 58(22). 2614–2626.e7. 11 indexed citations
5.
Yang, Qiyuan, Pengpeng Liu, Tomer Shpilka, et al.. (2022). LONP-1 and ATFS-1 sustain deleterious heteroplasmy by promoting mtDNA replication in dysfunctional mitochondria. Nature Cell Biology. 24(2). 181–193. 59 indexed citations
6.
Iyer, Sukanya, Aamir Mir, Joel Vega‐Badillo, et al.. (2022). Efficient Homology-Directed Repair with Circular Single-Stranded DNA Donors. The CRISPR Journal. 5(5). 685–701. 25 indexed citations
7.
Luk, Kevin, Pengpeng Liu, Jing Zeng, et al.. (2022). Optimization of Nuclear Localization Signal Composition Improves CRISPR-Cas12a Editing Rates in Human Primary Cells. PubMed. 1(3). 271–284. 16 indexed citations
8.
Vinjamur, Divya S., Qiuming Yao, Mitchel A. Cole, et al.. (2021). ZNF410 represses fetal globin by singular control of CHD4. Nature Genetics. 53(5). 719–728. 50 indexed citations
9.
Liu, Jesse, et al.. (2021). Telogen effluvium associated with COVID‐19 infection. Dermatologic Therapy. 34(2). e14761–e14761. 46 indexed citations
10.
Zeng, Jing, Yuxuan Wu, Chunyan Ren, et al.. (2020). Therapeutic base editing of human hematopoietic stem cells. Nature Medicine. 26(4). 535–541. 205 indexed citations
11.
Nagpal, Neha, Jing Zeng, Kevin Luk, et al.. (2020). Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells. Cell stem cell. 26(6). 896–909.e8. 59 indexed citations
12.
Iyer, Sukanya, Sneha Suresh, Dongsheng Guo, et al.. (2019). Precise therapeutic gene correction by a simple nuclease-induced double-stranded break. Nature. 568(7753). 561–565. 85 indexed citations
13.
Kim, Daesik, Kevin Luk, Scot A. Wolfe, & Jin‐Soo Kim. (2019). Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases. Annual Review of Biochemistry. 88(1). 191–220. 122 indexed citations
14.
Liu, Pengpeng, Kevin Luk, Masahiro Shin, et al.. (2019). Enhanced Cas12a editing in mammalian cells and zebrafish. Nucleic Acids Research. 47(8). 4169–4180. 76 indexed citations
15.
Rao, Shuquan, Qiuming Yao, Kevin Luk, et al.. (2019). Gene Editing ELANE in Human Hematopoietic Stem and Progenitor Cells Reveals Disease Mechanisms and Therapeutic Strategies for Severe Congenital Neutropenia. Blood. 134(Supplement_1). 3–3. 5 indexed citations
16.
Bolukbasi, Mehmet Fatih, Pengpeng Liu, Kevin Luk, et al.. (2018). Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing. Nature Communications. 9(1). 4856–4856. 23 indexed citations
17.
Afshar, Mehdi, Kevin Luk, Ron Do, et al.. (2017). Association of Triglyceride-Related Genetic Variants With Mitral Annular Calcification. Journal of the American College of Cardiology. 69(24). 2941–2948. 25 indexed citations
18.
Krishnamoorthy, Vijay, Ali Rowhani‐Rahbar, Edward F. Gibbons, et al.. (2017). Early Systolic Dysfunction Following Traumatic Brain Injury: A Cohort Study. Critical Care Medicine. 45(6). 1028–1036. 41 indexed citations
19.
Chen, Hao Yu, Line Dufresne, Hermann Burr, et al.. (2017). Association of LPA Variants With Aortic Stenosis. JAMA Cardiology. 3(1). 18–18. 43 indexed citations
20.
Kessler, Harald H., Bryan Cobb, Heiner Wedemeyer, et al.. (2015). Evaluation of the COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study. Journal of Clinical Virology. 67. 67–72. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026